Obsidian Therapeutics, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: OBX
Obsidian Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker OBX. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2017.
Obsidian Therapeutics at a glance
What does Obsidian Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $32.4 million sold (2017).
Frequently asked questions about Obsidian Therapeutics
Where is Obsidian Therapeutics headquartered?
Obsidian Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Obsidian Therapeutics do?
Obsidian Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Obsidian Therapeutics a public company?
Yes. Obsidian Therapeutics, Inc. trades on Nasdaq under the ticker OBX.
When was Obsidian Therapeutics founded?
The earliest incorporation on record for Obsidian Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences